Bharat Book Bureau

Archives for aggregator

The US House of Representatives has passed legislation paving the way for major healthcare system reform designed to substantially decrease the number of individuals without health insurance. US healthcare reform: a double-edged sword The US House of Representatives has passed legislation paving the way for major healthcare system reform designed to substantially decrease the number… » read more

Posted by bharatbook

Daiichi Sankyo: new influenza drug may boost flagging Japanese market Tokyo-based Daiichi Sankyo has filed a New Drug Application in Japan for its inhaled influenza antiviral, laninamivir. This neuraminidase inhibitor, administered in just a single inhaled dose, retains activity to strains resistant to the market leader, Roche’s Tamiflu. As such, its approval may provide a… » read more

Posted by bharatbook

Sanofi-Aventis has announced the withdrawal of its US and EU applications for the approval of eplivanserin as a treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance. Sanofi-Aventis: CNS franchise takes a knock Sanofi-Aventis has withdrawn its US and EU applications for its insomnia candidate, eplivanserin. Previously posited to emerge as a… » read more

Posted by bharatbook

MedImmune has agreed to license the rights to develop Trellis Bioscience’s monoclonal antibody products for the treatment of respiratory syncytial virus (RSV). MedImmune: collaboration with Trellis strengthens RSV pipeline MedImmune has agreed to license the rights to develop Trellis Bioscience’s monoclonal antibody products for the treatment of respiratory syncytial virus (RSV). MedImmune already has one… » read more

Posted by bharatbook

The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose patent protection and become exposed to generic competition. Big Pharma seeks to insulate itself from impact of patent cliff The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose… » read more

Posted by bharatbook

ASH 2009: Novartis looks to position Tasigna as an alternative to Gleevec in CML At this year’s American Society of Hematology meeting, researchers presented results from a Phase III study comparing Tasigna and Gleevec in newly diagnosed chronic myeloid leukemia. While Tasigna’s efficacy is impressive, it is unlikely that the drug will achieve the same… » read more

Posted by bharatbook

This year’s American College of Rheumatology Annual Conference in Philadelphia. No ground-breaking data for rheumatoid arthritis therapies were presented; instead, systemic lupus erythematosus stole the limelight. ACR 2009: Benlysta outshines disappointing rheumatoid arthritis data This year’s American College of Rheumatology Annual Conference in Philadelphia. No ground-breaking data for rheumatoid arthritis therapies were presented; instead, systemic… » read more

Posted by bharatbook

Bharatbook added a new report on “Solar Photovoltaic Market in India 2010” which gives a brief study on the Photovoltaic technology and the overall solar photovoltaic market in India. Solar Photovoltaic Market in India 2010 Report ( http://www.bharatbook.com/detail.asp?id=141482&rt=Solar-Photovoltaic-Market-in-India-2010.html ) assesses that the Solar photovoltaic (SPV) market in India is at nascent stage but has huge… » read more

Posted by bharatbook

Bharatbook added a new report on “2010 Preqin PE Real Estate Fund of Funds Review” which gives comprehensive profiles of PERE fund of funds managers, including its detailed investment plans. 2010 Preqin PE Real Estate Fund of Funds Review Private equity real estate fund of funds vehicles perform a vital function within the PERE industry,… » read more

Posted by bharatbook

Bharatbook added a new report on “Women’s Health Diagnostic Testing” gives overall women’s health market and its rapid development. Women’s Health Diagnostic Testing report ( http://www.bharatbook.com/detail.asp?id=141422&rt=Womens-Health-Diagnostic-Testing.html ) describes the specific segment of the in vitro diagnostics (IVDs) market called women’s health testing. This study includes contemporary and generally accepted clinical and analytical activities. This analysis… » read more

Posted by bharatbook